Morgan Stanley Maintains Exelon(EXC.US) With Hold Rating, Maintains Target Price $39
Barclays Adjusts Price Target on Exelon to $41 From $39
Exelon Analyst Ratings
Exelon (EXC) Gets a Buy From Barclays
Exelon Analyst Ratings
Morgan Stanley Adjusts Exelon Price Target to $39 From $41
Exelon (EXC) Receives a Buy From Barclays
Exelon Analyst Ratings
Morgan Stanley Adjusts Price Target on Exelon to $41 From $38, Keeps Equalweight Rating
Exelon (EXC) Receives a Rating Update From a Top Analyst
Exelon (EXC) Receives a Buy From BMO Capital
Exelon Analyst Ratings
Goldman Sachs Adjusts Price Target on Exelon to $38 From $37
KeyBanc Remains a Hold on Exelon (EXC)
Exelon Analyst Ratings
Exelon Analyst Ratings
Barclays Keeps Their Buy Rating on Exelon (EXC)
RBC Capital Reaffirms Their Hold Rating on Exelon (EXC)
Exelon Receives Confident Buy Rating Amidst Strong Q4 Earnings and Proactive Financial Strategy
Scotiabank Remains a Hold on Exelon (EXC)
No Data